The API 3200MD and QTRAP systems identify organic or inorganic compounds in human specimens.
After obtaining the CE-IVDD regulatory mark for both devices, the company is able to offer each system for use in European hospitals and clinical laboratories.
The two mass spectrometry IVD technology systems are intended for use within the clinical diagnostics market and LC/MS/MS capabilities seek to simplify routine analysis.
Features overview:
- Simultaneous qualitative and quantitative analysis.
- Combines triple quadruple specificity in sample runs.
- Data and analysis reproducibility.
